We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.
- Authors
Robins, S J; Collins, D; Wittes, J T; Papademetriou, V; Deedwania, P C; Schaefer, E J; McNamara, J R; Kashyap, M L; Hershman, J M; Wexler, L F; Rubins, H B; VA-HIT Study Group. Veterans Affairs High-Density Lipoprotein Intervention Trial
- Abstract
A low plasma level of high-density lipoprotein cholesterol (HDL-C) is a major risk factor for coronary heart disease (CHD). A secondary prevention study, the Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT), demonstrated that CHD events were significantly reduced during a median follow-up of 5.1 years by treating patients with the fibric acid derivative gemfibrozil when the predominant lipid abnormality was low HDL-C.
- Publication
JAMA, 2001, Vol 285, Issue 12, p1585
- ISSN
0098-7484
- Publication type
Journal Article
- DOI
10.1001/jama.285.12.1585